views: 1181
Readers community rating: votes 0
1. Akulova E., Murashev B., Nazarenko O., Verevochkin S., Masharsky A., Krasnoselskih T., Lioznov D., Sokolovsky E. and Kozlov A. P. Immune Responses Induced by Candidate Optimized HIV DNA Vaccine in Phase I Clinical Trial // Madridge Journal of Vaccines. 2017;1(1):35–44.
2. Murashev B., Kazennova E., Kozlov A., Murasheva I., Dukhovlinova E., Galachyants Y., Dorofeeva E., Dukhovlinov I., Smirnova G., Masharsky A., Klimov N., Kozlov A. P. Immunogenicity of candidate DNA vaccine based on subtype A of human immunodefi ciency virus type 1 predominant in Russia // Biotechnol J. 2007 Jul;2(7):871–8.
3. Murashev B. V., Nazarenko O. V., Akulova E. B., Artemyeva A. K., Verevochkin S. V., Shaboltas A. V., Skochilov R. V., Toussova O. V., Kozlov A. P. The high frequency of HIV type 1-specifi c cellular immune responses in seronegative individuals with parenteral and/or heterosexual HIV type 1 exposure // AIDS Res Hum Retroviruses. 2012 Dec;28(12):1598–605. doi: 10.1089/AID.2011.0335.